跳至主要内容
临床试验/CTRI/2024/07/071720
CTRI/2024/07/071720尚未招募不适用

Effectiveness Of Individualized Homoeopathic Medicine In The Treatment Of Contact Dermatitis Using Eczema Area And Severity Index :A Single Blind Randomized Placebo Controlled Trial

DR GAYATRIBEN BALUBHAI CHAUHAN1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年9月12日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
1.Homoeopathic Medicines are effective in Contact Dermatitis.

研究概览

简要总结

The study is a randomized ,single blind ,parallel group ,placebo controlled trial comparing individualized homoeopathic medicine group for patients with contact dermatitis .

the primary outcome is difference in outcome between homoeopathy group and placebo group in cases of contact dermatitis .to assess the severity of patients before and

after treatment in cases of contact dermatitis using eczema area and severity index .

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Pre-diagnosed cases of Contact Dermatitis.
  • 2.All Socio-economic status.
  • 3.Subjects who give informed consent to participate in study.
  • 4.Cases which have EASI SCORE less then 51 of contact dermatitis.

排除标准

  • 1.Patient having severe, non treatable complication of Contact Dermatitis.
  • 2.Advanced and irreversible pathological cases which require immediate medical attention.
  • 3.Cases which have EASI SCORE more than 51 very severe disease contact dermatitis 4.Patients taking other modes of treatment for contact dermatitis.
  • 5.Contact Dermatitis in pregnant and lactating women.

结局指标

主要结局

1.Homoeopathic Medicines are effective in Contact Dermatitis.

时间窗: 15 days

2.Reduction in symptoms of Contact Dermatitis.

时间窗: 15 days

次要结局

  • 1.To evaluate the outcome in homoeopathic medicinal group & placebo group by analyzing the improvement in the Contact Dermatitis With The Help Of ECZEMA AREA AND SEVERITY INDEX.(2.To assess the severity of patients before & after treatment in cases of Contact Dermatitis Using ECZEMA AREA AND SEVERITY INDEX.)

研究者

发起方
DR GAYATRIBEN BALUBHAI CHAUHAN
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR GAYATRIBEN BALUBHAI CHAUHAN

JAWAHARLAL NEHRU HOMOEOPATHIC MEDICAL COLLEGE

研究点 (1)

Loading locations...

相似试验